Fig. 2From: Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational researchPyrograms comparing the tumors KRAS exon 2, codon 12 mutational status in a October 2010 (wildtype sequence GGTGGC) and b October 2014 (point mutation p.G12 V, c. 35 G > T, sequence GTTGGC)Back to article page